Rakesh Popat Selected Research

Rakesh Popat Research Topics

Disease

54	Multiple Myeloma 01/2024 - 06/2005
8	Neoplasms (Cancer) 01/2024 - 10/2007
7	Immunoglobulin Light-chain Amyloidosis 01/2022 - 01/2018
5	Infections 10/2023 - 01/2020
4	Disease Progression 07/2023 - 12/2016
4	Neutropenia 01/2023 - 10/2007
4	Thrombocytopenia (Thrombopenia) 01/2021 - 10/2007
3	Hypertension (High Blood Pressure) 02/2023 - 01/2020
2	Lymphoma (Lymphomas) 01/2023 - 11/2021
2	B-Cell Lymphoma (Lymphoma, B Cell) 01/2023 - 01/2020
2	Amyloidosis 09/2020 - 01/2020
1	Plasmacytoma 09/2023
1	Fatigue 09/2023
1	Pain (Aches) 09/2023
1	Lymphopenia (Lymphocytopenia) 02/2023
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2023
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2023
1	Hypophosphatemia 01/2023
1	Body Weight (Weight, Body) 11/2022
1	Sepsis (Septicemia) 11/2022
1	COVID-19 09/2022
1	Hyperglycemia 11/2021
1	Hematologic Neoplasms (Hematological Malignancy) 09/2021
1	Hemolytic Anemia 01/2021
1	Thrombosis (Thrombus) 01/2021
1	Thrombotic Microangiopathies 01/2021
1	Asymptomatic Infections 01/2021
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2020
1	Pneumonia (Pneumonitis) 12/2020
1	Septic Shock (Toxic Shock Syndrome) 12/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2020
1	Necrosis 12/2018
1	Residual Neoplasm 11/2018
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 10/2013

Drug/Important Bio-Agent (IBA)

22	Bortezomib (Velcade)FDA Link 02/2023 - 06/2005
20	Dexamethasone (Maxidex)FDA LinkGeneric 09/2023 - 06/2005
12	belantamab mafodotinIBA 12/2023 - 12/2018
9	Lenalidomide (CC 5013)FDA Link 09/2023 - 01/2015
7	Melphalan (Alkeran)FDA LinkGeneric 07/2023 - 10/2007
7	Immunoconjugates (Immunoconjugate)IBA 01/2023 - 12/2018
6	B-Cell Maturation AntigenIBA 10/2023 - 12/2018
6	Proteasome InhibitorsIBA 11/2022 - 12/2018
5	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 10/2023 - 12/2018
4	daratumumabIBA 10/2023 - 01/2018
4	carfilzomibIBA 02/2023 - 12/2019
4	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 06/2005
4	PanobinostatIBA 12/2020 - 12/2016
3	pomalidomideIBA 09/2023 - 01/2017
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2023 - 01/2021
3	Histone Deacetylase InhibitorsIBA 01/2018 - 10/2013
2	Chimeric Antigen ReceptorsIBA 01/2024 - 01/2021
2	Bispecific AntibodiesIBA 01/2024 - 10/2023
2	Immunomodulating AgentsIBA 11/2022 - 01/2020
2	Amyloid (Amyloid Fibrils)IBA 01/2022 - 01/2020
2	ixazomibIBA 01/2021 - 01/2020
2	Monoclonal AntibodiesIBA 09/2020 - 01/2020
2	AntigensIBA 09/2020 - 12/2018
2	Thalidomide (Thalomid)FDA Link 01/2019 - 12/2016
1	Surface Antigens (Surface Antigen)IBA 01/2024
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 10/2023
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 09/2023
1	Tyrosine (L-Tyrosine)FDA Link 01/2023
1	Syk KinaseIBA 01/2023
1	Interleukin-2 (IL2)IBA 01/2023
1	Amylases FDA Link 01/2023
1	LigandsIBA 01/2023
1	fms-Like Tyrosine Kinase 3IBA 01/2023
1	isatuximabIBA 11/2022
1	iberdomideIBA 11/2022
1	Mechanistic Target of Rapamycin Complex 1IBA 11/2021
1	TOR Serine-Threonine KinasesIBA 11/2021
1	Hypoglycemic Agents (Hypoglycemics)IBA 11/2021
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 11/2021
1	Insulin (Novolin)FDA Link 11/2021
1	talazoparibIBA 09/2021
1	Cytotoxins (Cytolysins)IBA 01/2021
1	RO6870810IBA 01/2021
1	Lysine (L-Lysine)FDA Link 12/2020
1	Histone DemethylasesIBA 12/2020
1	venetoclaxIBA 12/2020
1	TAK-659IBA 01/2020
1	Alkylating AgentsIBA 12/2018
1	Cell Surface ReceptorsIBA 12/2018
1	monomethylauristatin FIBA 12/2018
1	Immunologic Factors (Immunomodulators)IBA 12/2018
1	RNA (Ribonucleic Acid)IBA 11/2018
1	Biomarkers (Surrogate Marker)IBA 12/2017

Therapy/Procedure

18	Therapeutics 10/2023 - 06/2005
8	Stem Cell Transplantation 07/2023 - 10/2007
4	Drug Therapy (Chemotherapy) 09/2022 - 10/2007
2	Immunotherapy 01/2024 - 10/2023
2	Transplantation 02/2023 - 10/2007
1	Subcutaneous Injections 11/2022
1	Treatment Delay 09/2022
1	Salvage Therapy 01/2021
1	Premedication 01/2021
1	Immunomodulation 01/2021
1	Resistance Training 01/2020
1	Intravenous Infusions 01/2020
1	Drug Tapering 01/2017